Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants.

Authors:
Quirk EK; Brown EL; Leavitt RY; Mogg R; Mehrotra DV and 3 more

Journal:
Open Forum Infect Dis

Publication Year: 2014

DOI:
10.1093/ofid/ofu016

PMCID:
PMC4324197

PMID:
25734089

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Open Forum Infect Dis

Abbreviation: Open Forum Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Infectious Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022.
Barfield RK; Brown ML; Albrecht B and 27 more (2024) - Transparency Score: 3/6
Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential…
Stewart J; Ruiz-Mercado G; Sperring H and 3 more (2024) - Transparency Score: 3/6
Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordanc…
Matsuo T; Wurster S; Jiang Y and 2 more (2024) - Transparency Score: 3/6
Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syring…
Loy DE; Kamis K; Kanatser R and 1 more (2024) - Transparency Score: 2/6
Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data …
Kohler M; Brown JA; Tschumi N and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential conflicts of interest.  All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Potential conflicts of interest."

Evidence found in paper:

"Financial support.  These studies were sponsored and funded by Merck . Financial support."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025